Mitchell Smith, Chair at Fulcrum Metals, discusses turning waste into Gold & future growth

focusIR - A podcast by focusIR

Categories:

Mitchell Smith, non-exec Chairman of Fulcrum Metals (AIM:FMET), talks about his transition from a non-executive director to the non-executive chairman at the company and explains why he's excited about the company's evolution into a business focusing on tailings reprocessing. In this interview, investors will also learn: - Why Fulcrum Metals has now pivoted to tailings reprocessing over the last year - Why a technology driven gold recovery company is a perfect fit for the current international Gold market - How the positive results from the recent phase 2 study at its Tech Hughes tailings project in Ontario could indicate the future opportunity for the company - How the company can now achieve significant growth - What the upcoming milestones for the company will be and how they could prove to be the catalysts for valuing the companyReasons to add #FMET to your Watchlist: 1 Breakthrough Gold Recovery Technology – Fulcrum’s non-toxic leaching method doubles gold recovery rates compared to traditional cyanide-based methods, significantly improving extraction efficiency 2 Low CapEx, Near-Term Gold Production – Fulcrum is not building new mines. Instead, it reprocesses existing mine waste, cutting costs and accelerating time to production (targeting 18-24 months) 3 Significant Gold Reserves in Tailings – With 200,000+ oz of gold in just two initial projects, Fulcrum has a scalable opportunity across 70+ mine waste sites in Canada’s richest gold camps. 4 Government & ESG Backing – The Canadian government has a CA$10Bn liability in abandoned tailings sites. Fulcrum’s process solves an environmental problem while creating economic value, making regulatory support a major advantage. 5 Major Growth Potential & Industry Interest – With new licensing deals, additional acquisitions, and potential global expansion, Fulcrum is positioned to scale rapidly in the mining and resource recovery sector. Mitchell Smith was interviewed by Katie Pilbeam for focusIR